An exploration of testicular cancer survivors' experience of ejaculatory dysfunction following retroperitoneal lymph node dissection-a sub-study of the PREPARE clinical trial.
Ejaculation
Health-related quality of life
Survivor
Testicular cancer
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
20 Nov 2023
20 Nov 2023
Historique:
received:
29
08
2023
accepted:
20
10
2023
medline:
20
11
2023
pubmed:
20
11
2023
entrez:
19
11
2023
Statut:
aheadofprint
Résumé
Ejaculatory dysfunction secondary to retrograde ejaculation or anejaculation is a complication of retroperitoneal lymph node dissection (RPLND) for survivors of testicular cancer. We explored survivors' experiences of ejaculatory dysfunction following RPLND. In a sub-study of a single-arm phase 2 clinical trial (ACTRN12622000537752/12622000542796), participants reporting ejaculatory dysfunction ≥ 6 months following RPLND were invited to complete semi-structured interviews. Purposive sampling was used. Interviews continued until thematic saturation occurred, and codebook thematic analysis of interviews was performed. Of 58 individuals recruited to the trial, 33 (57%) reported ejaculatory dysfunction. Of these, 32 (97%) agreed to interview and 15 participated. Participants interviewed had median age 34 years (range 24-66), 12 (80%) in a long-term relationship with median time from surgery 36 months (range 11-112). Three overarching themes were identified. The first reflected the value of RPLND despite ejaculatory dysfunction. The second illuminated the impact(s) of ejaculatory dysfunction closely mapped to life stage, with flow-on impacts to fertility, sex, psychological wellbeing and communication. The third reflected information needs. Fertility was a substantial source of concern for some participants. Ejaculatory dysfunction had no effect on sex for some, whilst for others, sex was less pleasurable. Some reported benefits. Few reported ejaculatory dysfunction challenged masculinity, confidence, or self-esteem. Future research should examine interventions to reduce distress related to fertility, challenged masculinity and body image. Whilst most participants considered ejaculatory dysfunction to have little impact on their sexual function and relationships, some reported significant difficulties varying by life stage and relationship status.
Identifiants
pubmed: 37981616
doi: 10.1007/s11764-023-01489-9
pii: 10.1007/s11764-023-01489-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Gerdtsson A, Håkansson U, Törnblom M, Jancke G, Negaard HFS, Glimelius I, et al. Surgical complications in postchemotherapy retroperitoneal lymph node dissection for nonseminoma germ cell tumour: a population-based study from the Swedish Norwegian testicular cancer group. Eur Urol Oncol. 2020;3(3):383–9.
Daneshmand S, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, et al. Surgery in early metastatic seminoma: a phase II trial of retroperitoneal lymph node dissection for testicular seminoma with limited retroperitoneal lymphadenopathy. J Clin Oncol. 2023;41(16):3009–18. https://doi.org/10.1200/JCO.22.00624 .
doi: 10.1200/JCO.22.00624
pubmed: 36913642
Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol. 2006;13(10):1311–6.
doi: 10.1111/j.1442-2042.2006.01535.x
pubmed: 17010010
Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med. 2008;5(1):194–8.
doi: 10.1111/j.1743-6109.2007.00456.x
pubmed: 17433085
Jefferys A, Siassakos D, Wardle P. The management of retrograde ejaculation: a systematic review and update. Fertil Steril. 2012;97(2):306–12.
doi: 10.1016/j.fertnstert.2011.11.019
pubmed: 22177462
Lu S, Cui Y, Li X, Zhang H, Hu J, Liu J, et al. Sperm retrieval in anejaculatory diabetic men who failed in drug treatment and penile vibratory stimulation during blood sugar under control. Andrologia. 2014;46(4):370–3.
doi: 10.1111/and.12087
pubmed: 23488950
Mehta A, Sigman M. Management of the dry ejaculate: a systematic review of aspermia and retrograde ejaculation. Fertil Steril. 2015;104(5):1074–81.
doi: 10.1016/j.fertnstert.2015.09.024
pubmed: 26432530
Shoshany O, Abhyankar N, Elyaguov J, Niederberger C. Efficacy of treatment with pseudoephedrine in men with retrograde ejaculation. Andrology. 2017;5(4):744–8.
doi: 10.1111/andr.12361
pubmed: 28380686
Safarinejad MR. Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study. Int J Impot Res. 2019;21(4):213–20.
doi: 10.1038/ijir.2009.19
Hamilton RJ, Nayan M, Anson-Cartwright L, Atenafu EG, Bedard PL, Hansen A, et al. Treatment of relapse of clinical stage I nonseminomatous germ cell tumors on surveillance. J Clin Oncol. 2019;37(22):1919–26.
doi: 10.1200/JCO.18.01250
pubmed: 30802156
Heidenreich A, Haidl F, Paffenholz P, Pape C, Neumann U, Pfister D. Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours. Ann Oncol. 2017;28(2):362–7.
doi: 10.1093/annonc/mdw605
pubmed: 27831507
Lipphardt ME, Albers P. Late relapse of testicular cancer. World J Urol. 2004;22(1):47–54.
doi: 10.1007/s00345-004-0397-9
pubmed: 15064970
Donohue JP. Retroperitoneal lymphadenectomy: the anterior approach including bilateral suprarenal-hilar dissection. Urol Clin North Am. 1977;4(3):509–21.
doi: 10.1016/S0094-0143(21)01182-4
pubmed: 610039
Nazareth I, Lewin J, King M. Sexual dysfunction after treatment for testicular cancer: a systematic review. J Psychosom Res. 2001;51(6):735–43.
doi: 10.1016/S0022-3999(01)00282-3
pubmed: 11750296
Revenig L, Leung A, Hsiao W. Ejaculatory physiology and pathophysiology: assessment and treatment in male infertility. Transl Androl Urol. 2014;3(1):41–9.
pubmed: 26816751
pmcid: 4708301
Beyer J, Collette L, Sauvé N, Daugaard G, Feldman DR, Tandstad T, et al. Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-update consortium. J Clin Oncol. 2021;39(14):1553–62. https://doi.org/10.1200/JCO.20.03292 .
doi: 10.1200/JCO.20.03292
pubmed: 33729863
pmcid: 8099394
Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, et al. Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium. J Clin Oncol. 2021;39(14):1563–74.
doi: 10.1200/JCO.20.03296
pubmed: 33822655
pmcid: 8099402
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.
doi: 10.1093/intqhc/mzm042
pubmed: 17872937
Brooks J, McCluskey S, Turley E, King N. The utility of template analysis in qualitative psychology research. Qual Res Psychol. 2015;12(2):202–22.
doi: 10.1080/14780887.2014.955224
pubmed: 27499705
Barbour R. Analyzing and presenting qualitative research. In: Introducing Qualitative Research: A Student's Guide. SAGE Publications, Inc., 2014. https://doi.org/10.4135/9781526485045 .
Barbour R. Analysis: processing, coding and interrogating data. In: Introducing Qualitative Research: A Student's Guide. SAGE Publications, Inc., 2014. https://doi.org/10.4135/9781526485045 .
Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, et al. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer. 2005;93(2):200–7.
doi: 10.1038/sj.bjc.6602677
pubmed: 15999104
pmcid: 2361550
Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40 576 testicular cancer patients: focus on long-term survivors. JNCI. 2005;97(18):1354–65.
doi: 10.1093/jnci/dji278
pubmed: 16174857
Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28(30):4649–57.
doi: 10.1200/JCO.2010.29.9362
pubmed: 20855830
Smith AB, King M, Butow P, Luckett T, Grimison P, Toner GC, et al. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psychooncology. 2013;22(11):2557–64.
doi: 10.1002/pon.3323
pubmed: 23825010
Smith AB, Rutherford C, Butow P, Olver I, Luckett T, Grimison P, et al. A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors. Psychooncology. 2018;27(4):1129–37.
doi: 10.1002/pon.4596
pubmed: 29171109
Kvammen Ø, Myklebust T, Solberg A, Møller B, Klepp OH, Fosså SD, et al. Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953–2015: a population-based prospective cohort study. PLoS ONE. 2019;14(12):e0225942.
doi: 10.1371/journal.pone.0225942
pubmed: 31851716
pmcid: 6919610
Morton LM. Testicular cancer as a model for understanding the impact of evolving treatment strategies on the long-term health of cancer survivors. JNCI Cancer Spectr. 2020;4(3). https://doi.org/10.1093/jncics/pkaa013 .
Hellesnes R, Myklebust T, Fosså SD, Bremnes RM, Karlsdottir Á, Kvammen Ø, et al. Testicular cancer in the cisplatin era: causes of death and mortality rates in a population-based cohort. J Clin Oncol. 2021;39(32):3561–73.
doi: 10.1200/JCO.21.00637
pubmed: 34388002
Doyle R, Craft P, Turner M, Paterson C. Identifying the unmet supportive care needs of individuals affected by testicular cancer: a systematic review. J Cancer Surviv. 2022. https://doi.org/10.1007/s11764-022-01219-7 .
doi: 10.1007/s11764-022-01219-7
pubmed: 35781623
Nappi L, Thi M, Adra N, Hamilton RJ, Leao R, Lavoie JM, et al. Integrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumors. Eur Urol. 2021;79(1):16–9.
doi: 10.1016/j.eururo.2020.10.024
pubmed: 33158661
Leão R, Nayan M, Punjani N, Jewett MAS, Fadaak K, Garisto J, et al. A new model to predict benign histology in residual retroperitoneal masses after chemotherapy in nonseminoma. Eur Urol Focus. 2018;4(6):995–1001.
doi: 10.1016/j.euf.2018.01.015
pubmed: 29428550
Walter J, Lohman M, Kundu S, Xu S. A new fertility risk rating system for surgical, radiotherapy, and chemotherapy interventions used in testicular cancer. Transl Cancer Res. 2016;5:S778–81.
doi: 10.21037/tcr.2016.10.90
Moody JA, Ahmed K, Yap T, Minhas S, Shabbir M. Fertility managment in testicular cancer: the need to establish a standardized and evidence-based patient-centric pathway. BJU Int. 2019;123:160–72.
doi: 10.1111/bju.14455
pubmed: 29920910
Skoogh J, Steineck G, Johansson B, Wilderäng U, Stierner U. Psychological needs when diagnosed with testicular cancer: findings from a population-based study with long-term follow-up. BJU Int. 2013;111(8):1287–93.
doi: 10.1111/j.1464-410X.2012.11696.x
pubmed: 23469865
Rincones O, Smith A, Naher S, Mercieca-Bebber R, Stockler M. An updated systematic review of quantitative studies assessing anxiety, depression, fear of cancer recurrence or psychological distress in testicular cancer survivors. Cancer Manag Res. 2021;13:3803–16.
doi: 10.2147/CMAR.S198039
pubmed: 34007213
pmcid: 8123967
Narayan P, Lange PH, Fraley EE. Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J Urol. 1982;127(4):685–8.
doi: 10.1016/S0022-5347(17)53996-8
pubmed: 7069831
Ochsenkühn R, Kamischke A, Nieschlag E. Imipramine for successful treatment of retrograde ejaculation caused by retroperitoneal surgery. Int J Androl. 1999;22(3):173–7.
doi: 10.1046/j.1365-2605.1999.00165.x
pubmed: 10367237
Tomasi PA, Fanciulli G, Delitala G. Successful treatment of retrograde ejaculation with the alpha1-adrenergic agonist methoxamine: case study. Int J Impot Res. 2005;17(3):297–9.
doi: 10.1038/sj.ijir.3901253
pubmed: 15674403
Hsiao W, Deveci S, Mulhall JP. Outcomes of the management of post-chemotherapy retroperitoneal lymph node dissection-associated anejaculation. BJU Int. 2012;110(8):1196–200.
doi: 10.1111/j.1464-410X.2011.10852.x
pubmed: 22233208
Australian Government. Testicular cancer in Australia statistics 2022 [updated September 1, 2022, cited April 21, 2023. Available from: https://www.canceraustralia.gov.au/cancer-types/testicular-cancer/statistics.